© 1989 Oxford University Press
research-article |
Chloroform Inhibition of 1,2-Dimethylhydrazine-Induced Gastrointestinal Tract Tumors in the Fisher 344 Rat1
Genetic Toxicology Division, Health Effects Research Laboratory, U.S. Environmental Protection Agency 26 West Martin Luther King Drive, Cincinnati, Ohio 45268
Received September 9, 1988; accepted December 13, 1988
The effect of chloroform (CHCl3), administered at 0, 900, and 1800 mg/liter in the drinking water, on the carcinogenic potency of 1,2-dimethylhydrazine (DMH) was investigated. Groups of 40 male Fisher 344 rats were given one of the three drinking water solutions for 39 weeks following the subcutaneous injection of 200 mg/kg DMH, a known gastrointestinal (GI) tract carcinogen in this animal strain. When tumors from the GI tract were pooled there was a highly significant (p < 0.001) decrease in total number of tumors per group with increasing concentration of drinking water CHG3. In the control group (0 mg/liter CHCl3), 14/39 (36%) of the animals developed tumors of the GI tract, including the duodenum, jejunum, stomach, cecum, and colon. In contrast, the incidence of tumors in the two groups of rats given CHCl3 in the drinking water was significantly lower (p < 0.001; 900 mg/liter CHCl3, 12.8%; 1800 mg/liter CHCl3, 12.5%). A similar relationship was obtained when colon tumors were analyzed independently (p = 0.01). The incidence of total colon tumors obtained in the control group of this study (10/39, 26%) agrees well with the previous study by B. S. Reddy, K. Watanabe, and J. H. Weisburger (1977, Cancer Res. 37, 4156–4159) conducted in the same rat strain (7/30, 23%). These results demonstrate that CHCl3 in the drinking water inhibits carcinogenesis in the rat GI tract.